Publications by authors named "E M Schutz"
Background And Hypothesis: Donor-derived cell-free DNA (dd-cfDNA) shows good diagnostic performance for the detection of antibody-mediated rejection (AMR) in kidney transplant recipients (KTR). However, the clinical benefits of dd-cfDNA monitoring need to be established. Early diagnosis of AMR at potentially reversible stages may be increasingly important due to emerging treatment options for AMR.
View Article and Find Full Text PDFBackground And Objective: Cenobamate is a novel anti-seizure medication (ASM) with unusually high responder rates even in patients with refractory epilepsy. Due to its enzyme-inducing properties, cenobamate could negatively affect bone metabolism, similar to other ASMs; however, effects of long-term cenobamate treatment on bone health have not yet been investigated. The aim of this longitudinal observational study was to assess the effects of 1 year of continuous, adjunctive cenobamate treatment on bone health in patients with drug-resistant, focal epilepsy.
View Article and Find Full Text PDFArticle Synopsis
- This study evaluated four methods for determining permissible analytical imprecision (pCVA%) targets for several immunosuppressive drugs used in clinical settings.
- The methods considered biological variation, drug elimination half-life, and therapeutic ranges, with results showing average pCVA% values close to each other across the approaches.
- Although no single optimal method exists, the findings support a target of less than 6% pCVA%, as recommended by professional guidelines.
Asylum seekers' traumatic experiences in combination with discrimination, social isolation, and exclusion in the host country leads to low adherence from health and integration initiatives. Along with their inability to seek health care and physical inactivity, this situation increases their mental illness and, most importantly, decreases their well-being. In fact, the lack of well-being (e.
View Article and Find Full Text PDF